(Total Views: 118)
Posted On: 02/21/2017 11:01:24 AM
Post# of 102775
$IMLFF InMed Pharmaceuticals Inc. is a pre-clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid-based therapies to treat human diseases with high unmet medical needs. The Company has three core assets: a proprietary Bioinformatics assessment tool to match individual (or combination of) cannabinoids against disease targets, a proprietary Biosynthesis cannabinoid manufacturing system to economically produce all 90+ cannabinoids at pharmaceutical-grade (>99.5% purity), and drug development program.
The full research report has a comprehensive overview of InMed's financials, pipeline and potential obstacles READ MORE
(Copy and paste to your browser may be required to view the full report- http://bit.ly/2kA730w-IMLFF-Analyst)
https://finance.yahoo.com/news/inmeds-cannabi...00009.html
$VBIO $GWPH $AXIM
The full research report has a comprehensive overview of InMed's financials, pipeline and potential obstacles READ MORE
(Copy and paste to your browser may be required to view the full report- http://bit.ly/2kA730w-IMLFF-Analyst)
https://finance.yahoo.com/news/inmeds-cannabi...00009.html
$VBIO $GWPH $AXIM
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
